Opaleye Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-275,000
Closed -$1.43M 50
2024
Q3
$1.43M Buy
+275,000
New +$1.43M 0.24% 39
2024
Q2
Sell
-785,000
Closed -$3.86M 61
2024
Q1
$3.86M Buy
+785,000
New +$3.86M 0.84% 32